Red Door Wealth Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-152
Closed -$35K 435
2021
Q2
$35K Buy
+152
New +$27.2K 0.01% 287
2020
Q3
Sell
-25
Closed -$1K 290
2020
Q2
$1K Buy
+25
New +$1.37K ﹤0.01% 435

Other funds holding MRNA

Red Door Wealth Management's MRNA Position: Q3 2021 in Review

Red Door Wealth Management sold out of Moderna (MRNA) in Q3 2021, closing a stake of 152 shares — an estimated $35K sold.

Red Door Wealth Management first reported a position in MRNA in Q2 2020 and held it in 2 quarters. The position peaked at $35K in Q2 2021. 1,140 funds tracked by Wall St. Rank hold MRNA as of Q3 2021.

  • Red Door Wealth Management reported no remaining Moderna position as of Q3 2021 after selling out during the quarter.
  • Red Door Wealth Management sold 152 Moderna shares in Q3 2021, an estimated $35K.
  • Red Door Wealth Management first reported a position in Moderna in Q2 2020 and held it in 2 quarters.
  • Red Door Wealth Management's Moderna position peaked at $35K in Q2 2021.
  • 1,140 funds tracked by Wall St. Rank held Moderna as of Q3 2021.

Based on Red Door Wealth Management's 13F filing for Q3 2021, filed 14 Oct 2021.